Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM and Paraoxonase 1 Activity

Autor: Maes A, Carvalho Af, Moreira Eg, Maes M, Sirivichayakul S, Kanchanatawan B, Matsumoto Ak, Barbosa Ds, Michelin Ap, Geffard M, de Oliveira Semeão L, de Lima Pedrão Jv

Accumulating evidence suggests that TNF-α-mediated immune-neurotoxicity contributes to cognitive impairments and the overall severity of schizophrenia (OSOS). There are no data whether peripheral IL-6 and IL-4 may affect the phenome of schizophrenia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0c277724e4d6c1ca1bda78adcb5269b
https://doi.org/10.20944/preprints201911.0135.v1

In Schizophrenia, Low Natural IgM Antibody Titers to Oxidative Specific Epitopes and Higher IgM Responses to Nitrated and Nitrosylated Proteins Strongly Predict Negative Symptoms, Neurocognitive Impairments and the Deficit Syndrome

Autor: Kanchanatawan B, Sirivichayakul S, Carvalho Af, Maes M

Schizophrenia is characterized by an interrelated activation of the immune-inflammatory response system (IRS) and the compensatory immune-regulatory reflex system (CIRS), which downregulates the IRS. Deficit schizophrenia is characterized by a defici

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7aaee8348a41f3283746661611d73324

Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance-HIV drug resistance in sub-Saharan Africa and the Asia-Pacific

Autor: Hamers, Raph L., Oyomopito, Rebecca, Kityo, Cissy, Phanuphak, Praphan, Siwale, Margaret, Sungkanuparph, Somnuek, Conradie, Francesca, Kumarasamy, Nagalingeswaran, Botes, Mariette E., Sirisanthana, Thira, Abdallah, Saade, Li, Patrick C.K., Ngorima, Nicoletta, Kantipong, Pacharee, Osibogun, Akin, Lee, Christopher K.C., Stevens, Wendy S., Kamarulzaman, Adeeba, Derdelinckx, Inge, Chen, Yi Ming Arthur, Schuurman, Rob, Van vugt, Michèle, Rinke de wit, Tobias F., Njovu, C., Labib, M., Menke, J., Sanne, I., Wallis, C. L., Hardman, M., Wellington, M., Luthy, R., Mandaliya, K., Jao, I., Dolan, M., Namayanja, G., Nakatudde, L., Kiconco, M., Abwola, M., Mugyenyi, P., Ndembiz, N., Kaleebu, P., Akanmu, S., Wensing, A. M., Sigaloff, K., Straatsma, E., Lee, M. P., Wong, K. H., Saghayam, S., Pujari, S., Joshi, K., Merati, T. P., Yuliana, F., Low, L. L., Ong, L. Y., Mustafa, M., Nordin, N., Ditangco, R., Bantique, R. O., Wong, W. W., Yang, Y. W., Sirivichayakul, S., Piyavong, B., Praparattanapan, J., Kambua, P., Choi, J. Y., Han, S. H., Ratanasuwan, W., Sriondee, R., Kantor, R., Sohn, A. H., Messerschmidt, L., Singtoroj, T., Cooper, D. A., Law, M. G., Jiamsakul, A., Zhou, J.

Publikováno v: International Journal of Epidemiology, 41(1):dyq192, 43-54. Oxford University Press
International Journal of Epidemiology
Hamers, R L, Oyomopito, R, Kityo, C, Phanuphak, P, Siwale, M, Sungkanuparph, S, Conradie, F, Kumarasamy, N, Botes, M E, Sirisanthana, T, Abdallah, S, Li, P C K, Ngorima, N, Kantipong, P, Osibogun, A, Lee, C K C, Stevens, W S, Kamarulzaman, A, Derdelinckx, I, Chen, Y M A, Schuurman, R, Van vugt, M, Rinke de wit, T F, Njovu, C, Labib, M, Menke, J, Sanne, I, Wallis, C L, Hardman, M, Wellington, M, Luthy, R, Mandaliya, K, Jao, I, Dolan, M, Namayanja, G, Nakatudde, L, Kiconco, M, Abwola, M, Mugyenyi, P, Ndembiz, N, Kaleebu, P, Akanmu, S, Wensing, A M, Sigaloff, K, Straatsma, E, Lee, M P, Wong, K H, Saghayam, S, Pujari, S, Joshi, K, Merati, T P, Yuliana, F, Low, L L, Ong, L Y, Mustafa, M, Nordin, N, Ditangco, R, Bantique, R O, Wong, W W, Yang, Y W, Sirivichayakul, S, Piyavong, B, Praparattanapan, J, Kambua, P, Choi, J Y, Han, S H, Ratanasuwan, W, Sriondee, R, Kantor, R, Sohn, A H, Messerschmidt, L, Singtoroj, T, Cooper, D A, Law, M G, Jiamsakul, A & Zhou, J 2012, ' Cohort profile : The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance-HIV drug resistance in sub-Saharan Africa and the Asia-Pacific ', International Journal of Epidemiology, vol. 41, no. 1, dyq192, pp. 43-54 . https://doi.org/10.1093/ije/dyq192
International journal of epidemiology, 41(1), 43-54. Oxford University Press

This article discusses two multi-centre prospective cohort studies in Africa that assess the prevalence and incidence of HIV in people using the first-line ART treatment. Participants are enrolled in the study for approximately 18 months after which

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3784966081e46cef415380ab8dfcd87
https://doi.org/10.1093/ije/dyq192

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.